𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells

✍ Scribed by Eugenio Jiménez; Mercedes Montiel


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
378 KB
Volume
204
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Carbachol (Cch), a muscarinic acetylcholine receptor (mAChR) agonist, increases intracellular‐free Ca^2+^ mobilization and induces mitogen‐activated protein kinase/extracellular signal‐regulated kinase (MAPK/ERK) phosphorylation in MCF‐7 human breast cancer cells. Pretreatment of cells with the selective phospholipase C (PLC) inhibitor U73122, or incubation of cells in a Ca^2+^‐free medium did not alter Cch‐stimulated MAPK/ERK phosphorylation. Phosphorylation of MAPK/ERK was mimicked by phorbol 12‐myristate acetate (PMA), an activator of protein kinase C (PKC), but Cch‐evoked MAPK/ERK activation was unaffected by down‐regulation of PKC or by pretreatment of cells with GF109203X, a PKC inhibitor. However, Cch‐stimulated MAPK/ERK phosphorylation was completely blocked by myristoylated PKC‐ζ pseudosubstrate, a specific inhibitor of PKC‐ζ, and high doses of staurosporine. Pretreatment of human breast cancer cells with wortmannin or LY294002, selective inhibitors of phosphoinositide 3‐kinase (PI3K), diminished Cch‐mediated MAPK/ERK phosphorylation. Similar results were observed when MCF‐7 cells were pretreated with genistein, a non‐selective inhibitor of tyrosine kinases, or with the specific Src tyrosine kinase inhibitor PP2. Moreover, in MCF‐7 human breast cancer cells mAChR stimulation induced an increase of protein synthesis and cell proliferation, and these effects were prevented by PD098059, a specific inhibitor of the mitogen activated kinase kinase. In conclusion, analyses of mAChR downstream effectors reveal that PKC‐ζ, PI3K, and Src family of tyrosine kinases, but not intracellular‐free Ca^2+^ mobilization or conventional and novel PKC activation, are key molecules in the signal cascade leading to MAPK/ERK activation. In addition, MAPK/ERK are involved in the regulation of growth and proliferation of MCF‐7 human breast cancer cells. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Activation of mitogen-activated protein
✍ Kevin Yagle; Hailing Lu; Marina Guizzetti; Thomas Möller; Lucio G. Costa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

## Abstract Mitogen‐activated protein kinase (MAPK) can be phosphorylated by mitogens binding to G‐protein‐coupled receptors and is considered a major pathway involved in cell proliferation. In this study, we report on the activation of MAPK by muscarinic acetylcholine receptors in astroglial cells

Modulation of phosphatidylinositol-3-kin
✍ Imtiaz Ahmad Siddiqui; Vaqar Mustafa Adhami; Farrukh Afaq; Nihal Ahmad; Hasan Mu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

## Abstract We have earlier shown that oral infusion of a polyphenolic fraction isolated from green tea, at a human achievable dose (equivalent to six cups of green tea per day), significantly inhibits prostate cancer (PCA) development and metastasis in __tr__ansgenic __a__denocarcinoma of __m__ous

Cell growth inhibition by all-trans reti
✍ Shino Nakagawa; Teruhiko Fujii; Goro Yokoyama; Marcelo G. Kazanietz; Hideaki Yam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Abstract All‐trans retinoic acid (ATRA), a synthetic derivative of vitamin A, inhibits the growth of breast cancer cells. To elucidate the mechanism by which ATRA causes cell growth inhibition, we examined changes in cell cycle and intracellular signaling pathways, focusing on protein kinase C (

Synergistic antiproliferative and apopto
✍ Murielle Mimeault; Nicole Pommery; Jean-Pierre Hénichart 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 435 KB 👁 1 views

## Abstract Our results revealed that the blockade of epidermal growth factor receptor (EGFR) tyrosine kinase and protein kinase A (PKA) signaling pathways by specific inhibitors (PD153035 and Rp‐cAMPs) leads to a synergistic inhibition of EGF‐ and serum‐stimulated growth of human prostatic cancer